PMID: 18724415Aug 30, 2008Paper

Significant colonic neoplasia prevalence and ASGE recommendations: is it time for a change?

Journal of Clinical Gastroenterology
Dean KerenAlexandra Lavy

Abstract

To Evaluate the indications versus diagnostic yield of significant colonic neoplasia (SCN) in the open-access era and screening colonoscopy. During 6-year period, all procedural data were obtained from all consecutive patients who underwent colonoscopies. Indications were compared with American Society for Gastrointestinal Endoscopy guidelines. In all 22,341 procedures were included in the study. Indications were divided into 3 groups: Screening (21.89% of the procedures), surveillance (17.60%) and symptoms/signs (60.51%). A total of 2867 patients (12.83%) had SCNs. Of these, 278 (7.00%) SCNs were found in the group less than 50 years of age and 2589 in the group over the age of 50 years (14.10%). SCN as per indication frequency was 12.69% in the symptom/sign group (subdivided to 7.24% and 14.01% in the under 50 and over 50, age groups, respectively); screening 13.37% (5.48% and 15.09%, respectively); surveillance 12.64% (8.48% and 13.19%, respectively). The indications leading to the highest SCN rate (over 25%) were: abnormal imaging, elevated carcinoembryonic antigen, and rectal pain. Colonoscopy is a unique screening tool that can detect neoplastic lesions. SCN prevalence in our study was between 13% and 15% for all indicati...Continue Reading

References

Dec 1, 1979·Annals of Surgery·H Shinya, W I Wolff
Mar 5, 1992·The New England Journal of Medicine·W S AtkinJ Cuzick
Jan 1, 1990·Scandinavian Journal of Gastroenterology·E BrennaH Petersen
Nov 1, 1987·Gastroenterology·S J StrykerR L MacCarty
Dec 30, 1993·The New England Journal of Medicine·S J WinawerJ F Panish
Jan 20, 1998·Gastrointestinal Endoscopy·R E SchoenC Margulies
Dec 16, 1998·Gastrointestinal Endoscopy·J B Marshall
Apr 23, 1999·The Medical Journal of Australia·J Croese
Sep 29, 1999·Gastrointestinal Endoscopy·R J CharlesM V Sivak
May 11, 2000·Gastrointestinal Endoscopy·J M Inadomi, A Sonnenberg
Jul 20, 2000·The New England Journal of Medicine·T F ImperialeD F Ransohoff
Feb 22, 2001·Gastrointestinal Endoscopy
Jul 28, 2001·Gastrointestinal Endoscopy·S MoriniG Minoli
Jun 7, 2002·The New England Journal of Medicine·Thomas F ImperialeDavid F Ransohoff
Oct 4, 2002·European Journal of Gastroenterology & Hepatology·Yeng S AngDonald G Weir
Sep 27, 2003·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·L S FreedmanM Silbermann
Mar 1, 2005·European Journal of Internal Medicine·R J L F Loffeld, A B M M van der Putten
Oct 7, 2005·Journal of Clinical Gastroenterology·Gavin C Harewood, Garrett O Lawlor
Oct 20, 2005·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·David A LiebermanCynthia D Morris

❮ Previous
Next ❯

Citations

Jun 11, 2009·Current Opinion in Anaesthesiology·Martin LuginbühlFrank Stüber
Nov 9, 2011·Journal of General Internal Medicine·Dimitra Dodou, Joost C F de Winter
Jun 26, 2012·Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society·Li DengJian-Ping Yang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
R S Y WuT H Rainer
© 2022 Meta ULC. All rights reserved